Form4insider filings, from the source

Company · CIK 0001817229 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

Vor Biopharma Inc. · VOR

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $4,207 · 1net −$4,207
$10k$10k$100k$100k$1M$1MbuyssalesJul 15Jul 15Jul 15Jul 16Jul 16Jul 16Jul 17

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 24, 2026 MForm 4 →Aug 26, 6:28 pm EDTRA CAPITAL MANAGEMENT, L.P. +310% Owner1,500$3.74$5,6041,500—
Jul 16, 2026 SForm 4 →Jul 21, 4:54 pm EDTRA CAPITAL MANAGEMENT, L.P. +310% Owner213$19.75$4,2074,501,882−0.00% late
Jul 16, 2026 XForm 4 →Jul 21, 4:54 pm EDTRA CAPITAL MANAGEMENT, L.P. +310% Owner2,100,000$0.002$4,2004,502,095— late

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 24, 2026 MForm 4 →Aug 26, 6:28 pm EDTRA CAPITAL MANAGEMENT, L.P. +310% Owner1,500——0—
Jul 16, 2026 XForm 4 →Jul 21, 4:54 pm EDTRA CAPITAL MANAGEMENT, L.P. +310% Owner2,100,000$5.00$10,500,0007,900,000— late
Jul 7, 2026 AForm 4 →Jul 9, 4:01 pm EDTDavid ZaccardelliDirector42,658——42,658—
Jun 11, 2026 AForm 4 →Jun 12, 8:44 pm EDTRA CAPITAL MANAGEMENT, L.P. +3Director, 10% Owner57,162——57,162—
Jun 11, 2026 AForm 4 →Jun 12, 8:42 pm EDTMichel DetheuxDirector57,162——57,162—
Jun 11, 2026 AForm 4 →Jun 12, 8:42 pm EDTFouad NamouniDirector56,549——56,549—
Jun 11, 2026 AForm 4 →Jun 12, 8:41 pm EDTWouter JoustraDirector57,162——57,162—
Jun 11, 2026 AForm 4 →Jun 12, 8:41 pm EDTErez KalirDirector57,162——57,162—
Jun 11, 2026 AForm 4 →Jun 12, 8:40 pm EDTAlexander CumboDirector56,345——56,345—
Jun 11, 2026 AForm 4 →Jun 12, 8:40 pm EDTDaniella BeckmanDirector53,283——53,283—
Jun 11, 2026 AForm 4 →Jun 12, 8:39 pm EDTAndrew David LevinDirector57,162——57,162—